Mondrian Investment Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $21.4K | Sell |
1,438
-104
| -7% | -$1.55K | ﹤0.01% | 94 |
|
|
2024
Q4 | $20K | Sell |
1,542
-5,092,913
| -100% | -$66.2M | ﹤0.01% | 96 |
|
|
2024
Q3 | $71.3M | Sell |
5,094,455
-2,644,293
| -34% | -$37M | 1.08% | 44 |
|
|
2024
Q2 | $108M | Sell |
7,738,748
-4,341,214
| -36% | -$60.8M | 1.67% | 34 |
|
|
2024
Q1 | $169M | Buy |
12,079,962
+3,912,569
| +48% | +$54.8M | 2.32% | 13 |
|
|
2023
Q4 | $117M | Buy |
8,167,393
+4,085,678
| +100% | +$58.3M | 1.84% | 28 |
|
|
2023
Q3 | $61.2M | Hold |
4,081,715
| – | – | 1.26% | 42 |
|
|
2023
Q2 | $64.1M | Hold |
4,081,715
| – | – | 1.28% | 39 |
|
|
2023
Q1 | $67.3M | Sell |
4,081,715
-286,000
| -7% | -$4.71M | 1.48% | 32 |
|
|
2022
Q4 | $69.9M | Sell |
4,367,715
-384,000
| -8% | -$6.14M | 1.55% | 30 |
|
|
2022
Q3 | $61.8K | Hold |
4,751,715
| – | – | 1.35% | 30 |
|
|
2022
Q2 | $66.5M | Buy |
4,751,715
+432,000
| +10% | +$6.05M | 1.39% | 33 |
|
|
2022
Q1 | $60.5M | Buy |
4,319,715
+261,000
| +6% | +$3.65M | 1.24% | 37 |
|
|
2021
Q4 | $56.8M | Buy |
4,058,715
+355,311
| +10% | +$4.97M | 1.12% | 36 |
|
|
2021
Q3 | $59.3M | Hold |
3,703,404
| – | – | 1.2% | 32 |
|
|
2021
Q2 | $63M | Buy |
3,703,404
+193,000
| +5% | +$3.28M | 1.2% | 30 |
|
|
2021
Q1 | $59.7M | Buy |
3,510,404
+235,744
| +7% | +$4.01M | 1.28% | 31 |
|
|
2020
Q4 | $58.9M | Buy |
3,274,660
+225,186
| +7% | +$4.05M | 1.46% | 26 |
|
|
2020
Q3 | $45.7M | Buy |
3,049,474
+19,828
| +0.7% | +$297K | 1.58% | 21 |
|
|
2020
Q2 | $54.5M | Sell |
3,029,646
-399,524
| -12% | -$7.19M | 1.95% | 17 |
|
|
2020
Q1 | $51.4M | Sell |
3,429,170
-210,000
| -6% | -$3.15M | 1.8% | 15 |
|
|
2019
Q4 | $72.8M | Hold |
3,639,170
| – | – | 1.91% | 12 |
|
|
2019
Q3 | $61.9M | Buy |
3,639,170
+229,000
| +7% | +$3.89M | 2% | 11 |
|
|
2019
Q2 | $61.4M | Buy |
3,410,170
+397,300
| +13% | +$7.15M | 1.96% | 17 |
|
|
2019
Q1 | $60.3M | Buy |
3,012,870
+139,000
| +5% | +$2.78M | 1.9% | 20 |
|
|
2018
Q4 | $48.9M | Buy |
+2,873,870
| New | +$48.9M | 1.79% | 22 |
|